These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 23677008)

  • 41. Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.
    Li J; Butcher J; Mack D; Stintzi A
    Inflamm Bowel Dis; 2015 Jan; 21(1):139-53. PubMed ID: 25248007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current Understanding of Dysbiosis in Disease in Human and Animal Models.
    DeGruttola AK; Low D; Mizoguchi A; Mizoguchi E
    Inflamm Bowel Dis; 2016 May; 22(5):1137-50. PubMed ID: 27070911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alteration of the Gut Microbiome in Inflammatory Bowel Disease.
    Andoh A; Nishida A
    Digestion; 2023; 104(1):16-23. PubMed ID: 35901721
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of the fecal microbiome in cats with inflammatory bowel disease or alimentary small cell lymphoma.
    Marsilio S; Pilla R; Sarawichitr B; Chow B; Hill SL; Ackermann MR; Estep JS; Lidbury JA; Steiner JM; Suchodolski JS
    Sci Rep; 2019 Dec; 9(1):19208. PubMed ID: 31844119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bacterial flora in inflammatory bowel disease.
    Marteau P
    Dig Dis; 2009; 27 Suppl 1():99-103. PubMed ID: 20203504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD.
    Casén C; Vebø HC; Sekelja M; Hegge FT; Karlsson MK; Ciemniejewska E; Dzankovic S; Frøyland C; Nestestog R; Engstrand L; Munkholm P; Nielsen OH; Rogler G; Simrén M; Öhman L; Vatn MH; Rudi K
    Aliment Pharmacol Ther; 2015 Jul; 42(1):71-83. PubMed ID: 25973666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The human intestinal microbiota].
    Doré J; Corthier G
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S7-15. PubMed ID: 20889008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice.
    Hoffmann TW; Pham HP; Bridonneau C; Aubry C; Lamas B; Martin-Gallausiaux C; Moroldo M; Rainteau D; Lapaque N; Six A; Richard ML; Fargier E; Le Guern ME; Langella P; Sokol H
    ISME J; 2016 Feb; 10(2):460-77. PubMed ID: 26218241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microenvironmental Factors that Shape Bacterial Metabolites in Inflammatory Bowel Disease.
    Lopez LR; Ahn JH; Alves T; Arthur JC
    Front Cell Infect Microbiol; 2022; 12():934619. PubMed ID: 35959366
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enterobacteriaceae Growth Promotion by Intestinal Acylcarnitines, a Biomarker of Dysbiosis in Inflammatory Bowel Disease.
    Lemons JMS; Conrad M; Tanes C; Chen J; Friedman ES; Roggiani M; Curry D; Chau L; Hecht AL; Harling L; Vales J; Kachelries KE; Baldassano RN; Goulian M; Bittinger K; Master SR; Liu L; Wu GD
    Cell Mol Gastroenterol Hepatol; 2024; 17(1):131-148. PubMed ID: 37739064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
    Gonçalves P; Araújo JR; Di Santo JP
    Inflamm Bowel Dis; 2018 Feb; 24(3):558-572. PubMed ID: 29462379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.
    Lemoinne S; Kemgang A; Ben Belkacem K; Straube M; Jegou S; Corpechot C; ; Chazouillères O; Housset C; Sokol H
    Gut; 2020 Jan; 69(1):92-102. PubMed ID: 31003979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specific changes of enteric mycobiota and virome in inflammatory bowel disease.
    Chu Y; Jiang MZ; Xu B; Wang WJ; Chen D; Li XW; Zhang YJ; Liang J
    J Dig Dis; 2018 Jan; 19(1):2-7. PubMed ID: 29266753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-throughput sequencing provides insights into oral microbiota dysbiosis in association with inflammatory bowel disease.
    Qi Y; Zang SQ; Wei J; Yu HC; Yang Z; Wu HM; Kang Y; Tao H; Yang MF; Jin L; Zen K; Wang FY
    Genomics; 2021 Jan; 113(1 Pt 2):664-676. PubMed ID: 33010388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes.
    Sato J; Kanazawa A; Ikeda F; Yoshihara T; Goto H; Abe H; Komiya K; Kawaguchi M; Shimizu T; Ogihara T; Tamura Y; Sakurai Y; Yamamoto R; Mita T; Fujitani Y; Fukuda H; Nomoto K; Takahashi T; Asahara T; Hirose T; Nagata S; Yamashiro Y; Watada H
    Diabetes Care; 2014 Aug; 37(8):2343-50. PubMed ID: 24824547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inflammatory bowel disease: factors involved in pathogenesis.
    Dudík B; Sepová HK; Bilková A
    Ceska Slov Farm; 2018; 67(3):95-100. PubMed ID: 30630325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study.
    Muñiz Pedrogo DA; Chen J; Hillmann B; Jeraldo P; Al-Ghalith G; Taneja V; Davis JM; Knights D; Nelson H; Faubion WA; Raffals L; Kashyap PC
    Inflamm Bowel Dis; 2019 Apr; 25(5):902-913. PubMed ID: 30321331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The fingerprint of the human gastrointestinal tract microbiota: a hypothesis of molecular mapping.
    Tomasello G; Mazzola M; Jurjus A; Cappello F; Carini F; Damiani P; Gerges Geagea A; Zeenny MN; Leone A
    J Biol Regul Homeost Agents; 2017; 31(1):245-249. PubMed ID: 28337900
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut dysbiosis-related thrombosis in inflammatory bowel disease: Potential disease mechanisms and emerging therapeutic strategies.
    Papa A; Santini P; De Lucia SS; Maresca R; Porfidia A; Pignatelli P; Gasbarrini A; Violi F; Pola R
    Thromb Res; 2023 Dec; 232():77-88. PubMed ID: 37951044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intestinal Dysbiosis in Carriers of Carbapenem-Resistant
    Korach-Rechtman H; Hreish M; Fried C; Gerassy-Vainberg S; Azzam ZS; Kashi Y; Berger G
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32350099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.